Hospital Diagnoses Critically Ill Children Using Artificial Intelligence

DiploidThe Rady Children’s Hospital (San Diego, USA) used Moon, software developed by the Leuven-based (Belgium) company Diploid. Moon is the first software worldwide to use Artificial Intelligence (AI) for the diagnosis of rare diseases. This new method accelerates the diagnosis of seriously ill children in intensive care and opens the door to the use of genome sequencing as a first-line diagnostic test for babies with unknown disorders. An estimated 4 percent of newborns are affected by genetic diseases, which are the leading cause of death in infants. Rare genetic diseases also account for around 15 percent of admissions to children's hospitals.

"Some people call this artificial intelligence, we call it augmented intelligence," said Stephen Kingsmore, MD, DSc, President and CEO of RCIGM. "Patient care will always begin and end with the doctor. By harnessing the power of technology, we can quickly and accurately determine the root cause of genetic diseases. We rapidly provide this critical information to intensive care physicians so they can focus on personalizing care for babies who are struggling to survive."

By reducing the need for labor-intensive manual analysis of genomic data, the automated approach saved a considerable amount of time. In February 2018, the same team set the world record for the fastest diagnosis by sequencing the entire genome.

"Saving the lives of very sick newborn babies by using AI in genome analysis is truly groundbreaking work for the Rady team," said Eric Topol, MD, professor of molecular medicine at Scripps Research.

The Rady Children's Hospital has optimized various time-saving technologies and integrated them into a rapid process to screen the entire genetic composition of a child for thousands of genetic abnormalities, based on a blood sample.

A crucial element in this process is the Moon software developed by Diploid in Leuven. The platform automates the interpretation of the genetic data via AI to automatically filter and classify pathogenic mutations. Integration of the patient's symptoms, based on analysis of the medical literature, is one of the main pillars of this automated interpretation. With Moon, it takes only five minutes to find the causal mutation amidst the 4.5 million mutations in a fully human genome.

The study emphasizes that these automated diagnoses corresponded to manual interpretation by experts. The Leuven Moon software achieved 99 percent precision in 95 children with 97 genetic disorders.

"This publication of the Rady Children's Hospital is an absolute first," said Peter Schols, CEO of Diploid. "For the first time in history, an algorithm matches the precision of a geneticist in diagnosing rare diseases. Of course there is always a manual check by a geneticist and the treating physician, but as the research results indicate, our Moon software achieved 99% precision in finding the genetic cause, which is unseen in our sector. We are delighted with these results. The Rady Children's Hospital is one of the very best children's hospitals in the US and even worldwide, and it is an honor that they have chosen our software."

Researchers concluded that this highly automated approach allows the use of genome analysis in intensive care units, giving seriously ill children the rapid and accurate medical care they require.

Increased process automation removes a barrier to scaling up clinical use of genome sequencing by reducing the need for time-consuming manual analysis and interpretation of data by scarce clinical geneticists.

"Using machine-learning platforms doesn't replace human experts. Instead it augments their capabilities," said Michelle Clark, PhD, statistical scientist at RCIGM and the first author of the study. "By informing timely targeted treatments, rapid genome sequencing can improve the outcomes of seriously ill children with genetic diseases."

For further information, please visit:
http://www.diploid.com

About Rady Children's Hospital - San Diego

Rady Children's Hospital-San Diego is a 524-bed pediatric care facility providing the largest source of comprehensive pediatric medical services in San Diego, southern Riverside and Imperial counties. Rady Children's is the only hospital in the San Diego area dedicated exclusively to pediatric healthcare and is the region’s only designated pediatric trauma center. In June 2018, U.S. News & World Report ranked Rady Children's among the best children's hospitals in the nation in all ten pediatric specialties the magazine surveyed. Rady Children’s is a nonprofit organization that relies on donations to support its mission.

About Diploid

Diploid is on a mission to provide clinical labs, hospitals and nationwide sequencing programs with the tools to diagnose every rare disease patient. Its MOON platform is the first software worldwide to use artificial intelligence for autonomous variant interpretation in rare disease diagnostics. Thanks to its use of advanced machine learning and deep phenotype integration, MOON is now widely recognized as the fastest genome interpretation solution, going from whole genome VCF to diagnosis in just minutes. In addition, MOON’s autopilot feature enables unsupervised reanalysis of negative cases, making continuous genome interpretation a reality.

About Leuven MindGate

Leuven MindGate was founded in 2016 when 29 leading knowledge institutions, companies and the city of Leuven joined forces. These three parties represent the Leuven ecosystem in a so-called Triple Helix model.

One of Leuven MindGate's goals is positioning the Leuven region internationally as a top destination in Health, High-Tech and Creativity. Leuven MindGate also improves cross-pollination between these sectors by letting them interact, cooperate and co-create. This creates a unique ecosystem and perfect breeding ground for companies, entrepreneurs, investors and international talent.

Leuven MindGate participates in national and international projects, missions, trade fairs and constantly aims to make Leuven MindGate worldwide top of mind when it comes to health, high-tech and creativity.

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

DigiConnect: e-healthcare - 24/7 Health …

Given the current outbreak of COVID-19, healthcare providers in the Middle East along with the rest of the world are currently putting relentless efforts to provide an innovative offering that...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...